Novo Nordisk A/S ADR buy BTIG Research
Start price
29.03.23
/
50%
€144.50
Target price
29.03.24
€28.58
Performance (%)
-16.96%
End price
30.03.24
€120.00
Summary
This prediction ended on 30.03.24 with a price of €120.00. The price of Novo Nordisk A/S ADR has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -16.96%. A total of €1.43 was paid as dividends for this prediction. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novo Nordisk A/S ADR | -1.660% | -1.660% | -23.052% |
| iShares Core DAX® | 3.178% | 0.980% | 15.331% |
| iShares Nasdaq 100 | 2.972% | 0.925% | 39.831% |
| iShares Nikkei 225® | 0.545% | -4.556% | 17.661% |
| iShares S&P 500 | 2.367% | 0.833% | 30.000% |
Comments by BTIG_Research for this prediction
In the thread Novo Nordisk A/S ADR diskutieren
Novo Nordisk A/S (NYSE: NVO) had its price target raised by analysts at BTIG Research from $20.00 to $31.00. They now have a "buy" rating on the stock.
Ratings data for NVO provided by MarketBeat
In the thread Trading Novo Nordisk A/S ADR
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten